GlassScriptPhysician profile
David A Melendez
NPI 1205190683
$7,113.65
in general payments reported to CMS, 2019-2025
26 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $343 · 2021: $1,090 · 2022: $1,071 · 2023: $1,513 · 2024: $859 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,687 · Travel and Lodging: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,686.75 |
| Travel and Lodging | $1,563.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,024.42 | 2021-2025 | Titan |
| Boston Scientific Corporation | $819.43 | 2019-2023 | Rezum Generator |
| Endo Pharmaceuticals INC. | $400.43 | 2021-2023 | Xiaflex, Aveed |
| Astellas Pharma US INC | $216.13 | 2019-2022 | |
| Axonics, INC. | $182.46 | 2023 | Axonics |
| Urogen Pharma, INC. | $177.39 | 2022-2024 | |
| Janssen Biotech, INC. | $170.07 | 2021-2022 | |
| Lumenis, INC | $151.49 | 2021 | |
| Karl Storz Endoscopy-America | $146.36 | 2022 | |
| Clarus Therapeutics INC. | $146.06 | 2021 | |
| Procept Biorobotics Corporation | $119.82 | 2025 | |
| Teleflex LLC | $85.14 | 2021-2023 | Urolift |
| Endo USA, INC. | $78.34 | 2024-2025 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $67.51 | 2021-2022 | |
| Pfizer INC. | $50.85 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $45.13 | 2022 | |
| Intuitive Surgical, INC. | $38.38 | 2022 | |
| Laborie Medical Technologies Corp. | $31.11 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Smith+Nephew, INC. | $26.12 | 2022 | |
| Olympus America INC. | $23.59 | 2023 | Itind System |
| Ethicon US, LLC | $23.13 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.91 | 2025 | Exparel |
| Urovant Sciences INC | $19.77 | 2022 | |
| Dentsply Ih INC. | $18.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.66 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Melendez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.